18F-Fluciclovine
Showing 1 - 25 of >10,000
Brain Metastases Trial in Tucson (18F-Fluciclovine PET/CT)
Not yet recruiting
- Brain Metastases
- 18F-Fluciclovine PET/CT
-
Tucson, ArizonaArizona Cancer Center at UMC North/University Medical Center
Sep 20, 2023
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the
Not yet recruiting
- Multiple Myeloma
- +2 more
- 18F-fluciclovine injection
- 18F-FDG PET/CT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 31, 2023
Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)
Not yet recruiting
- Brain Metastases
- +2 more
- 18F fluciclovine
-
Miami, FloridaMiami Cancer Institute
Sep 15, 2023
Brain Metastases Trial in Houston (18F-Fluciclovine (Axumin), Pet Scan)
Not yet recruiting
- Brain Metastases
- 18F-Fluciclovine (Axumin)
- Pet Scan
-
Houston, TexasM D Anderson Cancer Center
Aug 23, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023
Brain Metastases, Brain Cancer Trial in Miami (18F-Fluciclovine)
Not yet recruiting
- Brain Metastases
- Brain Cancer
- 18F-Fluciclovine
-
Miami, FloridaMiami Cancer Institute at Baptist Health South Florida
Jan 3, 2023
Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)
Recruiting
- Brain Tumor
- Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 6, 2022
Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Houston (Computed Tomography, Fluciclovine F18,
Terminated
- Metastatic Prostate Carcinoma
- Stage IVB Prostate Cancer AJCC v8
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)
Not yet recruiting
- Grade III or Grade IV Glioma
- PET imaging with 18F fluciclovine
- (no location specified)
Jul 27, 2022
Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)
Recruiting
- Glioma
- +4 more
- 18F-Fluciclovine PET-MRI
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Dec 22, 2022
Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)
Not yet recruiting
- Glioma
- +4 more
- 18F-Fluciclovine
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 3, 2022
Glioma Trial in Pittsburgh (18F-fluciclovine)
Recruiting
- Glioma
- 18F-fluciclovine
-
Pittsburgh, PennsylvaniaUPMC Hospitals
Feb 7, 2022
18F-fluciclovine PET/MRI Imaging for Detection of Tumor
Suspended
- Metastatic Intracranial Malignant Neoplasm
- Recurrent Intracranial Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Positron Emission Tomography
- Fluciclovine F18
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 27, 2021
Brain Metastases, Adult, Brain Metastases, Brain Cancer Trial in Miami (18F fluciclovine)
Recruiting
- Brain Metastases, Adult
- +2 more
- 18F fluciclovine
-
Miami, Florida
- +1 more
Apr 11, 2022
Prostate Cancer, Prostate Nodule Trial in Houston (18F-fluciclovine)
Not yet recruiting
- Prostate Cancer
- Prostate Nodule
- 18F-fluciclovine
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Feb 14, 2022
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Trial in Houston
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022
Lymphoma, Non-Hodgkin, CNS Tumors Trial in Trondheim (18F-FDG, 18F-fluciclovine, standard MRI)
Recruiting
- Lymphoma, Non-Hodgkin
- Central Nervous System Neoplasms
- 18F-FDG
- +2 more
-
Trondheim, NorwayNorwegian University of Science and Technology, Department of Ci
Dec 15, 2021
Bladder Cancer, Urothelial Carcinoma Trial in Boston (18F-fluciclovine, PET/CT)
Recruiting
- Bladder Cancer
- Urothelial Carcinoma
- 18F-fluciclovine
- PET/CT
-
Boston, MassachusettsDana Farber Cancer Institute
Apr 4, 2022
Pancreatitis, Graft, Pancreatic Transplant Post-Transplant Dysfunction Rejection Trial in Salt Lake City (18F-fluciclovine)
Enrolling by invitation
- Pancreatitis, Graft
- Pancreatic Transplant Post-Transplant Dysfunction Rejection
- 18F-fluciclovine
-
Salt Lake City, UtahUniversity of Utah Hospital
Sep 27, 2021
Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Computed Tomography
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 9, 2022
Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8
Not yet recruiting
- Stage II Nasopharyngeal Carcinoma AJCC v8
- +2 more
- Biopsy
- +16 more
- (no location specified)
Oct 7, 2023
Glioma Glioblastoma Multiforme Trial in Philadelphia (Axumin, Intravenous Solution)
Completed
- Glioma Glioblastoma Multiforme
- Axumin, Intravenous Solution
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Dec 21, 2021
Brain Tumor, Recurrent, Adult Trial in Loma Linda (PET/CT with F-Fluciclovine (Axumin))
Recruiting
- Brain Tumor, Recurrent, Adult
- PET/CT with F-Fluciclovine (Axumin)
-
Loma Linda, CaliforniaLoma Linda University Cancer Center
Sep 20, 2021
Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (18F-fluciclovine PET Scan)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- 18F-fluciclovine PET Scan
-
New Orleans, LouisianaTulane Cancer Center Clinic
Oct 8, 2021
Prostate Cancer Patients With Biochemical Recurrence
Active, not recruiting
- Patients With Prostate Cancer
- Pelvic CT or MRI + MDP bone scan + or - 18F-NaF PET/CT(SOC)
-
Saint Louis, MissouriJohn Cochran VA Medical Center St. Louis
May 10, 2022